Emma Coleen McDonnell

Emma McDonnell practices at Surgery Center of California in Chula Vista, California.

Emma McDonnell's NPI, 1023357670, was assigned on February 1, 2013. Emma McDonnell graduated from The Johns Hopkins University School of Medicine in 2015. Emma McDonnell's Maryland license number on file is D87058.

Emma McDonnell's primary practice is Surgery Center of California, at 835 3rd Avenue, Suite A, Chula Vista, CA 91911. The practice phone is (619) 425-4209.

Emma McDonnell's primary practice is Surgery Center of California in Chula Vista, California. The medical group on file is Johns Hopkins University. Dmand AI also links Emma McDonnell to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Emma McDonnell practices. Vendor and product names are available with a free account.

Ophthalmology is Emma McDonnell's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Emma McDonnell is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Emma McDonnell's licenses on file in 2 states: Maryland and California.

Dmand AI lists age-related macular degeneration, conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, hereditary corneal conditions and vision problems among the conditions Emma McDonnell treats.

CMS data shows 4,796 Medicare services from Emma McDonnell across 19 procedure codes in 2024, for 782 Medicare patients. Medicare paid $244,267 for them.

CMS counts 782 Medicare patients who saw Emma McDonnell in 2024. The largest group is 65 to 74, with 373 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 72% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Emma McDonnell's median patient age at 66, with 67% women.

In 2024, Emma McDonnell wrote 1,501 Medicare Part D claims for 648 patients. 55% of them were for generic drugs. CMS names the drug for 1,377 of them, across 12 drugs with 11 or more claims each, at $93,790 in total drug cost. In 2023, CMS named 1,143 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Emma McDonnell for performance year 2024, reported as part of a group. Emma McDonnell accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Emma McDonnell, published from 2011 to 2022. The most frequent topics are Eyelids and Tomography, Optical Coherence. Emma McDonnell has published most often in Ophthalmic Plast Reconstr Surg. Emma McDonnell's most frequent co-authors are Ronald Mancini, MD, Ramsudha Narala, MD and Srinivas Reddy Sadda, MD.

CMS Open Payments shows 57 general payments to Emma McDonnell from 14 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Sight Sciences, Inc. paid the most, $675.

Emma McDonnell graduated from The Johns Hopkins University School of Medicine in 2015.

Emma McDonnell is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.